In vitro studies
|
Antifungal |
Leaves |
Essential oil |
− |
Disc diffusion method |
Essential oil extracted from M. koenigii exhibited activities with MIC in the range of 25.5 to 75 μg/mL against pathogenic fungi A. niger, F. moniliforme, P. notatum, M. mucedo, and P. funiculosum
|
[27] |
Antibacterial |
Leaves |
Solvent-free microwave extraction |
− |
Soy agar |
Minimum inhibitory concentrations (MIC) of solvent-free microwave extraction (SFME) and hydro-distilled oil from M. koenigii with values of 400 and 600 μg/mL against L. innocua SFME-essential oil at 300 μg/mL provided 92% inhibition, indicating its antibacterial potential |
[37] |
Antibacterial |
Leaves |
Methanol |
Koenine, koenigine, and mahanine |
Broth micro-dilution assay |
Koenine, koenigine, and mahanine extracted from M. koenigii exhibited activities with MIC values of 3.12–12.5 µg/mL against bacterial strains S. aureus and K. pneumonia
|
[40] |
Antibacterial |
Leaves |
Aqueous |
− |
Agar diffusion assay |
M. koenigii-AGNPs exhibited inhibitory activity against E. coli and S. aureus, with a value of 16 mm for M. koenigii-AgNPs and 15 mm for AgNO3 solution at 100 µg/well |
[18] |
Antibacterial |
Leaves |
Essential oil |
− |
Microtiter assay |
Essential oil extracts of M. koenigii treatment resulted in a reduction of biofilm formation in P. aeruginosa PAO1. M. koenigii essential oil may effectively control Pseudomonas biofilms in indwelling medical device |
[19] |
Antibacterial |
Leaves |
Petroleum ether, ethanol, and water |
− |
Colony-forming unit (CFU) assay |
Ethanol extracts of M. koenigii exhibited activity half maximal inhibitory concentration ((IC50) of 400 μg/mL) against the mycobacterium smegmatis compared to petroleum ether and water extracts |
[20] |
Hepatoprotective |
Leaves |
Aqueous |
− |
Hep G2 cell line |
M. koenigii leaves preventing alcohol-induced cellular damage |
[31] |
Antioxidant |
Leaves |
Ethanol |
− |
DPPH free radical scavenging assay |
exhibited activities with IC50 values of 21.4–49.5 µg/mL |
[21] |
Antioxidant |
Leaves |
Aqueous |
− |
TBARS, CAT, SOD, and glutathione (GSH) assay |
Carbazole alkaloids from M. koenigii extract exhibited activity with IC50 values of 120 μg/mL in an ethanol-induced hepatotoxicity in vitro model |
[31] |
Antioxidant |
Leaves |
Aqueous/zinc oxide nanoparticles |
− |
DPPH free radical scavenging assay |
Zinc oxide nanoparticle-synthesized M. koenigii extract exhibited activity with an IC50 value of 36.46 μg/mL |
[64] |
Antioxidant |
Leaves |
Aqueous/zinc oxide nanoparticles |
− |
ABTS radical scavenging assay |
Zinc oxide nanoparticle-synthesized M. koenigii extract exhibited activity with an IC50 value of 11.55 μg/mL |
[64] |
Antioxidant |
Leaves |
Aqueous/zinc oxide nanoparticles |
− |
Superoxide assay |
Zinc oxide nanoparticle-synthesized M. koenigii extract exhibited activity with an IC50 value of 11.47 μg/mL |
[64] |
Antioxidant |
Leaves |
Aqueous/zinc oxide nanoparticles |
− |
H2O2 Assay |
Zinc oxide nanoparticle-synthesized M. koenigii extract exhibited activity with an IC50 value of 54.06 μg/mL |
[64] |
Antioxidant |
Leaves |
Ethanoic |
− |
DPPH free radical scavenging assay |
The ethanoic extract of M. koenigii showed an 80% scavenging activity, which was similar to the activities exhibited by the control antioxidant compound quercetin |
[66] |
Antioxidant |
Leaves |
Aqueous, alcohol, and acetone |
− |
DPPH free radical scavenging assay |
The extracts of M. koenigii exhibited activities with an EC50 value of acetone of 4.7 µg/mL, alcohol of 4.1 µg/mL, and aqueous of 4.4 µg/mL, which were comparable to the EC50 value of 2.6 µg/mL exhibited by ascorbic acid, which was the positive control |
[67] |
Antioxidant |
Leaves |
Petroleum ether and ethyl acetate |
− |
Cupric-reducing antioxidant capacity |
CUPRAC assays indicated the highest reducing potential in the benzene fraction, followed by petroleum ether and ethyl acetate |
[68] |
Antioxidant |
Leaves |
Benzene, ethyl acetate, acetone, methanol, and ethanol |
− |
DPPH free radical scavenging assay |
Results showed that for 100 µg/mL, the benzene fraction extracted from M. koenigii showed 88.3% free radical scavenging activity, followed by ethyl acetate (79.5%), petrol ether (78.7%), acetone (66.1%), methanol (50.7%), and ethanol (53.0%) fractions, respectively, with the positive control being ascorbic acid (93.1%) |
[69] |
Antioxidant |
Fruits |
Aqueous |
− |
DPPH free radical scavenging assay |
Fruit extracted from M. koenigii exhibited activities with an EC50 value of 2.6 mg/mL |
[71] |
Cytotoxicity |
Stem bark and roots |
Hexane, chloroform, and methanol |
Girinimbine |
MTT assay |
Girinimbine was shown to significantly inhibit the proliferation of HT-29 cells with an IC50 value of 4.79 ± 0.74 μg/mL. |
[85] |
Cytotoxicity |
Leaves |
Ethanol |
Murrayazoline and O-methylmurrayamine A |
MTT assay |
Murrayazoline and O-methylmurrayamine A exhibited activities with IC50 values of 5.7 and 17.9 mM in both HEK-293 and HaCaT cell lines, respectively |
[86] |
Cytotoxicity |
− |
− |
Isolongifolene |
MTT assay |
Isolongifolene exhibited activities at 10 µM, showing a 90% viability in SH-SY5Y cells |
[87] |
Cytotoxicity |
Leaves |
Methanol |
− |
MTT assay |
M. koenigii methanolic extract exhibited activities with IC50 values >400 µg/mL in the CLS-354 cell line |
[96] |
Cytotoxicity |
Leaves |
Ethanol |
− |
MTT assay |
M. koenigii ethanolic extract exhibited activities with an IC50 value of 20 µg/mL in the mouse macrophage RAW 264.7 cell line |
[20] |
Cytotoxicity |
Leaves |
Hexane, ethyl acetate, and methanol |
− |
MTT assay |
Three extracts of M. koenigii exhibited were very active, with values of <1 μg/mL to 2.25 μg/mL, and were thus proved to be potent cytotoxic activity agents against HeLa cancer cells |
[11] |
Anti-inflammatory |
Stems |
Methanol |
Murrayakonine A, murrayanine, and O-methylmurrayamine-A |
Human peripheral blood mononuclear cells |
In vitro experiments showed murrayakonine A (IC50 10 µM), murrayanine (IC50 9.4 µM), and O-methylmurrayamine-A (IC50 7 µM) against TNF-α, and murrayanine (IC50 8.4 µM) and methylmurrayamine-A (IC50 8.4 µM) against IL-6, respectively |
[39] |
Anticancer (Colon) |
Leaves |
Ethanol |
O-methylmurrayamine 5.7–17.9 µM |
MCF-7 cells |
O-methylmurrayamine A exhibited anti-colon cancer activity through downregulation of the Akt/mTOR survival pathway and activation of the intrinsic pathway of apoptosis |
[86] |
Anticancer (Oral) |
Leaves |
Methanol |
Mahanine 15 μM |
CLS-354 cells |
Mahanine increased the expression of LC3B-II, cleaved caspase-3 proteins, and the inhibition of autophagic flux |
[96] |
Anticancer (Ovarian) |
Stem bark |
Methanol |
Girinimbine 10 µM |
Ovarian cancer cell line SKOV3/ SV40 |
Girinimbine was found to be mainly due to the induction of apoptosis and cell cycle arrest due to the inhibition of the PI3K/AKT/mTOR and Wnt/b-catenin signaling pathways |
[98] |
Anticancer (Breast) |
Leaves |
Aqueous acetone |
Koenimbin 4.89 μg/mL |
MCF7 breast cancer stem cells |
Koenimbin induced apoptosis in MCF7 cells that was mediated by cell death and regulated the mitochondrial membrane potential by downregulating Bcl2 and upregulating Bax, due to cytochrome c release from the mitochondria to the cytosol, and significantly downregulated the Wnt/β-catenin self-renewal pathway |
[98] |
Anticancer (Prostate) |
Leaves |
Aqueous acetone |
Koenimbin 3.73 μg/mL |
Prostate cancer stem cells |
Koenimbin induced apoptosis through the intrinsic signaling pathway and suppression of the translocation of cytoplasmic NF-κB into the nucleus, in addition to displaying potential for targeting PCSCs, as affirmed by the prostasphere formation and Aldefluor assay |
[99] |
Anticancer |
Leaves |
Methanol |
Mahanine 7.5 μM |
Glioma HS 683 cells |
Mahanine inhibited the cell migration and invasion and inhibited cell growth was simultaneous with the suppression of p-PI3K, p-AKT, and p-mTOR |
[96] |
Anticancer (Liver) |
Leaves |
Methanol |
Mahanine 25 μM |
HepG2, HuCCT1, and KKU-100 cells |
Mahanine showed potent cytotoxicity, with increased expression levels of MITF balance between the cellular stresses |
[13] |
Anticancer (Cervical) |
Leaves |
Methanol |
Mahanine 8.6 μM |
HeLa (HPV-18) and SiHa (HPV-16) cell line |
Mahanine and cisplatin synergistically displayed growth inhibitory activity in cervical cancer, the inhibition of STAT3 activation, cell migration, and induced apoptosis |
[14] |
Anticancer (Lung) |
Leaves |
Methanol |
Mahanine 15 μM |
NSCLC cancer cell line A549 |
Mahanine induced the impairment of mTORC2 through rictor inhibition and the destruction of NSCLC cancer cells |
[22] |
Anticancer (Colon) |
Leaves |
Methanol |
Mahanine 0–30 μM |
HCT116, HCT116, SW480, and Vero |
Mahanine synergistically activated the two tumor suppressors PTEN and p53/p73 and can potentially be used in combination therapy with 5-FU for the treatment of colon carcinoma |
[23] |
Anticancer (prostate) |
Leaves |
Methanol |
Mahanine 10 μM |
PC3 and LNCaP cell line |
Mahanine selectively degraded DNMT1 and DNM T3B via the ubiquitin-proteasomal pathway in a dose-dependent manner upon the inactivation of Akt signaling |
[24] |
Neuroprotective |
Leaves |
Methanol |
Isolongifolene 10 µM |
SH-SY5Y cells |
Isolongifolene was effectively attenuated in oxidative stress, mitochondrial dysfunction, and apoptosis |
[87] |
Neuroprotective |
Leaves |
Methanol |
O-methylmurrayamine A |
PC12 cells |
O-methylmurrayamine A possibly protects against DNA damage, apoptosis, and high levels of cell viability |
[35] |
In vivo studies
|
Antioxidant |
Leaves |
Aqueous |
− |
Male albino Wistar rat |
The oral administration of an M. koenigii leaf extract resulted in a significant reduction in the level of TBARS in both the plasma (3.64 ± 0.13) and pancreas (53.40 ± 2.13) of diabetic rats |
[61] |
Antioxidant |
Leaves |
Aqueous |
− |
Male albino Wistar rat |
The oral administration of an M. koenigii leaf extract resulted in a significant increase in the level of GSH in both the plasma (24.16 ± 1.30) and pancreas (19.52 ± 1.09) of diabetic rats |
[77] |
Antioxidant |
Leaves |
Aqueous |
− |
Male albino Wistar rat |
The oral administration of an M. koenigii leaf extract significantly restored the activity of SOD in the pancreas (3.69 ± 0.15) of diabetic rats |
[77] |
Antioxidant |
Leaves |
Aqueous |
− |
Male albino Wistar rat |
The oral administration of an M. koenigii leaf extract significantly restored the activity of CAT in the pancreas (12.94 ± 0.54) of diabetic rats |
[77] |
Antioxidant |
Leaves |
Aqueous |
− |
Male albino Wistar rat |
The oral administration of an M. koenigii leaf extract significantly restored the activity of GPx in the pancreas (5.86 ± 0.22) of diabetic rats |
[67] |
Antioxidant |
Leaves |
Ethanol |
− |
Sprague Dawley rats |
For 200 and 400 µg/mL b.w, the M. koenigii extract showed 80% inhibited free radical generation and 75% restored GSH levels |
[10] |
Antioxidant |
Leaves |
Water |
− |
Male albino Wistar rat |
Extract exhibited the potential to reduce lipid peroxidation activity in the liver (2.44 ± 0.029) and kidney (2.34 ± 0.09) in potassium dichromate-induced Wistar rats |
[38] |
Anti-inflammatory |
Stem bark and roots |
Hexane, chloroform, and methanol |
Girinimbine |
Adult zebrafish |
Girinimbine treatment significantly suppressed the IL-1β and TNF-α levels induced by peritoneal fluid mice |
[85] |
Anti-inflammatory |
Leaves |
Ethanol |
− |
Sprague Dawley rats |
Oral administration of an M. koenigii extract showed the reduced formation of oedema, with values of 43.28%, 59.67%, and 62.29% induced by carrageenan, histamine, and serotonin in rats |
[30] |
Hepatoprotective |
Leaves |
Hydro-ethanolic |
− |
Male Wistar rats |
M. koenigii leaves significantly decreased CCl4 -induced hepatotoxic in a time- and dose-dependent manner |
[16] |
Nephroprotective |
Leaves |
Aqueous |
− |
Male Wistar rats |
M. koenigii extract treatment significantly decreased the renal functional markers, like the blood urea nitrogen and creatinine level |
[28] |
Anti-Diabetic |
Leaves |
Ethanol |
− |
Swiss albino mice |
M. koenigii possesses antidiabetic activity and has antioxidant effects on STZ-NA-induced diabetes mellitus and particularly significantly decreased the HOMA-IR index |
[10] |
Anticancer (Colon) |
Stem bark and roots |
Hexane, chloroform, and methanol |
Girinimbine 1.5–100 µg/mL |
Zebrafish and Male ICR mice |
Girinimbine, supplementation specifically, resulted in the induction of apoptosis, the inhibition of inflammation, and a significant increase in cell numbers in the G0/G1 phase |
[85] |
Anticancer (Breast) |
Leaves |
Aqueous |
− |
Female BALB/c mice |
M. koenigii aqueous extract has potential for cytotoxicity, anti-inflammatory, and immunomodulatory effects and delays rather than inhibits tumor formation |
[12] |
Neuroprotective |
Leaves |
Methanol |
− |
Male albino mice |
M. koenigii is effective in attenuating memory impairment and oxidative stress and prevents abnormal oral movements |
[36] |
Neuroprotective |
Leaves |
Ethanol |
− |
Swiss albino mice |
M. koenigii supplementation resulted in an improvement of acetylcholine (ACh) and reduction in acetylcholinesterase (AChE). In addition, a significant elevation of serum biomarkers, and decline in creatinine, total cholesterol, urea nitrogen, and glucose levels, ameliorated the hepatic and renal functions in the normal ageing process |
[30] |
Neuroprotective |
Leaves |
Ethanol |
− |
Male swiss albino mice |
M. koenigii leaves elevated the acetylcholine level in the brain and ultimately improved memory impairment. In vitro, it showed BACE1 inhibition and was found to be a non-competitive inhibitor |
[33] |
Neuroprotective |
Leaves |
Methanol |
Isolongifolene 10 mg/kg b.w. |
Male albino Wistar rat |
Isolongifolene effectively attenuated behavioral impairment and oxidative stress, acting as an antiaging agent |
[34] |
Anti-anxiety and anti-depressant |
Leaves |
Aqueous |
− |
Swiss albino mice |
M. koenigii aqueous leaf extract reduced the despair behavior in experimental animal models, suggesting an anti-depressant-like activity and also reduced spontaneous locomotor activity |
[41] |